Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Caiming Xu
Observed names:
C. Xu,
Xu, Caiming
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute,
Hangzhou City University
Observed institutions:
City Of Hope National Medical Center,
City of Hope,
First Affiliated Hospital of Dalian Medical University,
Beckman Research Institute,
Hangzhou City University
ORCID:
0000-0001-7794-2301
Observed ORCID:
0000-0001-7794-2301
OpenAlex ID:
A5073120810
A machine-learning informed circulating microbial DNA signature for early diagnosis of esophageal adenocarcinoma
2025
·
Yuan Li
, Caiming Xu
, et al.
·
Gut Microbes
·
8
PDF
Governing the rise of AI in healthcare: A comparative governance document and implementation implications across five jurisdictions
2026
·
Jinsong Chen
, Mingli Pang
, et al.
·
Social Science & Medicine
·
6
Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC
2026
·
Yitong Pan
, Huan Yan
, et al.
·
Cell Discovery
·
6
PDF
Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
2026
·
Yuhan Fang
, Xiaoqing Wang
, et al.
·
MedComm
·
5
Spatial accessibility and equity of traditional Chinese medicine hospitals in Eastern China: application of improved two-step floating catchment area method
2026
·
Caiming Xu
, Tingyu Mu
, et al.
·
Frontiers in Public Health
·
4
PDF
Abstract 2987: Cordycepin inhibits Intrahepatic cholangiocarcinoma progression by targeting NAT10-mediated ac4C RNA modification of VCAN
2026
·
Yuting Zhao
, Yinzhao Chen
, et al.
·
Cancer Research
Abstract 7407: The NAT10-PBX1 ac4C axis disables MHC Class II antigen presentation to promote immune-cold cholangiocarcinoma
2026
·
Kai Luo
, Yuhan Fang
, et al.
·
Cancer Research
Physical, Physiological, and Cognitive Aspects of Diseased Patients
2026
·
Caiming Xu
, Neelu Sinha
, et al.
·
CRC Press eBooks
383P An exosome-based liquid biopsy assay for predicting therapeutic outcomes in patients with metastatic colorectal cancer treated with anti-EGFR therapy: Results from prospective, first-line, PULSE and POSIBA trials
2022
·
A. Goel
, C. Xu
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
10
Citation count:
29
H-index:
4
I10-index:
Year
Topic
Type